T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Select Water Solutions
WTTR
$2.63B
| $2.9M | ﹤0.01% |
145,129
+40,805
| +39% | +$715K |
|
1827
Astrana Health
ASTH
$1.73B
| $2.88M | ﹤0.01% |
62,163
+12,745
| +26% | +$459K |
|
1828
Avis
CAR
$3.75B
| $2.85M | ﹤0.01% |
19,299
+1,076
| +6% | +$237K |
|
|
HNGE
1829
Hinge Health
HNGE
$7.43B
| $2.85M | ﹤0.01% |
+34,323
| New | +$1.86M |
|
1830
iShares Russell 2000 ETF
IWM
$76.4B
| $2.85M | ﹤0.01% |
9,476
-6,845
| -42% | -$1.92M |
|
1831
Philips
PHG
$24.5B
| $2.85M | ﹤0.01% |
104,730
-12,072
| -10% | -$320K |
|
1832
Pediatrix Medical
MD
$2.11B
| $2.84M | ﹤0.01% |
112,020
+13,147
| +13% | +$299K |
|
1833
1st Source
SRCE
$2.06B
| $2.83M | ﹤0.01% |
34,731
+1,382
| +4% | +$103K |
|
1834
La-Z-Boy
LZB
$1.18B
| $2.83M | ﹤0.01% |
70,533
+8,590
| +14% | +$311K |
|
1835
Lakeland Financial Corp
LKFN
$1.46B
| $2.82M | ﹤0.01% |
45,747
+8,397
| +22% | +$506K |
|
1836
ePlus
PLUS
$2.34B
| $2.82M | ﹤0.01% |
33,918
-249,592
| -88% | -$20.8M |
|
1837
Kohl's
KSS
$2.08B
| $2.82M | ﹤0.01% |
159,237
+21,255
| +15% | +$315K |
|
1838
Syndax Pharmaceuticals
SNDX
$1.6B
| $2.8M | ﹤0.01% |
128,199
+21,066
| +20% | +$438K |
|
1839
Innodata
INOD
$2.31B
| $2.8M | ﹤0.01% |
37,006
+9,602
| +35% | +$705K |
|
1840
NeoGenomics
NEO
$2.45B
| $2.79M | ﹤0.01% |
191,496
+35,378
| +23% | +$341K |
|
1841
Strategic Education
STRA
$1.69B
| $2.79M | ﹤0.01% |
36,371
+3,516
| +11% | +$278K |
|
1842
United Fire Group
UFCS
$1.37B
| $2.79M | ﹤0.01% |
53,139
+6,807
| +15% | +$302K |
|
|
WLTH
1843
Wealthfront Corp
WLTH
$1.57B
| $2.78M | ﹤0.01% |
310,573
+285,852
| +1,156% | +$2.98M |
|
1844
Eos Energy Enterprises
EOSE
$1.13B
| $2.77M | ﹤0.01% |
471,565
-561,891
| -54% | -$3.91M |
|
1845
Sunstone Hotel Investors
SHO
$2.1B
| $2.77M | ﹤0.01% |
241,796
+39,681
| +20% | +$417K |
|
1846
Peoples Bancorp
PEBO
$1.41B
| $2.77M | ﹤0.01% |
72,033
+3,618
| +5% | +$126K |
|
1847
Tompkins Financial
TMP
$1.4B
| $2.76M | ﹤0.01% |
29,238
+5,155
| +21% | +$444K |
|
1848
PROG Holdings
PRG
$1.27B
| $2.76M | ﹤0.01% |
59,168
+6,967
| +13% | +$243K |
|
1849
Enerpac Tool Group
EPAC
$1.81B
| $2.76M | ﹤0.01% |
76,834
+11,802
| +18% | +$414K |
|
1850
Arcus Biosciences
RCUS
$3.22B
| $2.75M | ﹤0.01% |
89,202
+13,386
| +18% | +$331K |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.